10 patents currently held
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2031
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2037 · High confidence
Also notable
Ends Apr 2038 · High confidence
Also notable
Ends Jan 2039 · High confidence
Novel Lactobacillus Having Various Functions, and Use Thereof
US 11,202,811
The earliest of the three still in force, granted 2021 and renewed since. Its term ends first, in 2037.
Novel Lactic Acid Bacteria and Use Thereof
US 11,554,146
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Novel Lactic Acid Bacteria and Use Thereof
US 11,324,786
Granted 2022. Computed term ends 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Method of Treatment with Lactic Acid Bacteria (US 11,660,321) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 1 fee due Dec 2, 2026The maintenance fee for Composition for Preventing or Treating Osteoporosis, and Manufacturing Method Therefor (US 9,044,401) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Novel Lactic Acid Bacteria and Use Thereof (US 11,963,988) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method of Treatment with Lactic Acid Bacteria | 2 in force | to Sep 2040 |
| Novel Lactic Acid Bacteria and Use Thereof (2020) | 2 in force | to Jan 2039 |
| Novel Lactic Acid Bacteria and Use Thereof (2020) | 2 in force | to Apr 2038 |
| Novel Lactic Acid Bacteria and Use Thereof (2019) | 1 in force | to Feb 2043 |
| Novel Lactobacillus Having Various Functions, and Use Thereof | 1 in force | to Mar 2037 |
Patents held now
Soonest term end first.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,044,401 | Composition for Preventing or Treating Osteoporosis, and Manufacturing Method Therefor held by Navipharm Co., Ltd. and Dream Pharma Corporation In force · High confidence | In force | High confidence | |
| US 10,835,497 | Rivastigmine-Containing Sustained-Release Pharmaceutical Composition In force · High confidence | In force | High confidence | |
| US 11,202,811 | Novel Lactobacillus Having Various Functions, and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,554,146 | Novel Lactic Acid Bacteria and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,036,253 | Novel Lactic Acid Bacteria and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,963,988 | Novel Lactic Acid Bacteria and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,324,786 | Novel Lactic Acid Bacteria and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,778,991 | Method of Treatment with Lactic Acid Bacteria In force · High confidence | In force | High confidence | |
| US 11,660,321 | Method of Treatment with Lactic Acid Bacteria In force · High confidence | In force | High confidence | |
| US 12,447,184 | Novel Lactic Acid Bacteria and Use Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 2 patents in force now held by others · 1 application pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.